文献速递关节外科

因假体周围感染行髋关节翻修术后的临床结局:高手术量中心369例髋关节单中心研究,至少随访一年

Clinical Outcomes After Revision Hip Arthroplasty due to Prosthetic Joint Infection-A Single-Center Study of 369 Hips at a High-Volume Center With a Minimum of One Year Follow-Up.
PubMed 文献 · J Arthroplasty · 2023-09-01

该单中心研究纳入2008年1月至2021年9月因假体周围感染(PJI)行髋关节翻修且随访至少一年的369例髋,比较清创抗生素保留假体(DAIR)、一期翻修和二期翻修的预后。一年随访时26.6%患者再手术、7.9%死亡;DAIR后再手术风险最高(36.6%),一期翻修最低(20.2%)。早期感染中,与DAIR相比,一期翻修再手术风险近乎减半(HR 0.51,95%CI 0.31-0.84)且未增加死亡风险(HR 1.05,95%CI 0.5-2.2)。

要点

  • 一年随访再手术率26.6%(95%CI 22.2-31.2%),死亡率7.9%(95%CI 5.4-10.9%)。
  • DAIR后再手术风险最高(36.6%,95%CI 28.5-44.7%),一期翻修最低(20.2%,95%CI 13.4-28%)。
  • 早期感染中,一期翻修较DAIR再手术风险降低(HR 0.51,95%CI 0.31-0.84),死亡风险无显著差异(HR 1.05,95%CI 0.5-2.2)。

核心结论

  • 早期感染中采用一期翻修替代DAIR可能改善预后,降低再手术风险而不增加死亡率,但患者选择困难,需进一步研究。

研究设计与样本

  • 单中心研究,纳入2008年1月至2021年9月因PJI行髋关节翻修且随访至少一年的369例髋,其中DAIR 134例、一期翻修114例、二期翻修121例。

主要发现

  • 一年随访时26.6%(95%CI 22.2-31.2%)患者再手术,7.9%(95%CI 5.4-10.9%)死亡。
  • DAIR后再手术风险最高(36.6%,95%CI 28.5-44.7%),一期翻修最低(20.2%,95%CI 13.4-28%)。
  • 早期感染中,与DAIR相比,一期翻修再手术风险HR 0.51(95%CI 0.31-0.84),死亡风险HR 1.05(95%CI 0.5-2.2)。

临床怎么用

  • 作者认为,早期感染中采用一期翻修替代DAIR可能降低再手术风险而不增加死亡率,但患者选择困难,需进一步研究。

局限性

  • 原文结论指出患者选择困难,需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prosthetic joint infection (PJI) treatment decisions are traditionally based on treatment algorithms. There is, however, a lack of evidence to support the choice of these treatment algorithms. Therefore, we aimed to assess the one-year survival after PJI revision and compared different surgical strategies in a single-center setting. METHODS: Revisions of the hip due to PJI performed at our institution between January 2008 and September 2021 with at least one-year of follow-up were identified. In total, 134 debridement, antibiotics, and implant retentions (DAIRs), 114 one-stage revisions, and 121 two-stage revisions were performed. Infections were classified as early, acute hematogenous, and chronic. Survival was calculated using the Kaplan-Meier method and cumulative incidence function. Predictors of outcomes were examined with Fine-Gray regressions and Cox proportional hazards regressions. Subdistribution hazard ratios and hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated. RESULTS: At one-year follow-up, 26.6% (CI 22.2 to 31.2%) of the patients had undergone reoperation and 7.9% (CI 5.4 to 10.9%) had died. The risk for reoperation was highest after DAIR (36.6%, CI 28.5 to 44.7%) and lowest after one-stage revision (20.2%, CI 13.4 to 28%). Within the early infections, the one-stage revision almost halved the risk of reoperation (HR 0.51, CI 0.31 to 0.84) with no added mortality risk (HR 1.05, CI 0.5 to 2.2), when compared to DAIR. CONCLUSION: By utilizing 1-stage revision over DAIR in early infections, it might be possible to improve the prognosis by decreasing the risk of reoperation without increasing mortality. However, as the patient selection is undeniably difficult, more research is warranted.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Liukkonen R, Honkanen M, Skyttä E, et al. Clinical Outcomes After Revision Hip Arthroplasty due to Prosthetic Joint Infection-A Single-Center Study of 369 Hips at a High-Volume Center With a Minimum of One Year Follow-Up. J Arthroplasty. 2023. PMID: 37661070. doi:10.1016/j.arth.2023.08.078

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。